Arzan Wealth Advises on Acquisition of Global Pharmaceutical Testing Lab in Madison, Wisconsin, USA


(MENAFNEditorial)Dubai, United Arab Emirates, March 27, 2017, (ME NewsWire): Arzan Wealth (DIFC) Limited (‘Arzan Wealth’), a Dubai-based advisory firm regulated by the Dubai Financial Services Authority, is pleased to announce that it has advised on the acquisition of the freehold ownership of the Pharmaceutical Product Development (“PPD”) laboratories campus (The Property”), located in the university town of Madison, Wisconsin, USA. The 233,694 sq ft property consists of two parcels and is 100% leased to PPD with 11.5 years remaining. PPD is a world-leading contract research organization (CRO) providing chemistry, manufacturing and controls lab services for all phases of drug development. PPD is the fifth largest player in the world in the fragmented CRO industry with around 6 percent market share. The subject property is PPD’s only mission-critical location in the US for its Good Manufacturing Practices (GMP) business, and one of only two worldwide. Showing significant commitment to the Property, PPD has invested substantial funds in the building. Arzan Wealth acted as the Strategic Advisor on the structuring and acquisition of the Property, and will continue in this role during the holding period of this investment. Muhannad Abulhasan, CEO of Arzan Wealth said: “We are pleased to be able to advise our clients on the acquisition of the PPD global research and testing laboratory campus, providing them with a very attractive and secure income flow with the possibility for capital gains from ‎some value-add opportunities that have been identified. This transaction exemplifies the philosophy of Arzan Wealth, which is based on the pursuit of high quality assets that offer our clients capital protection and a predictable monthly income stream, especially as the world faces major political and economic risks.” *Source: ME NewsWire Contacts: Ahmad AlSabbrei Senior Investment Analyst a.alsabbrei@arzanwealth.com +965 9988 8624

MENAFN2703201700703371ID1095347685


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.